Aerobec

Trials studying Aerobec

• phase3A Study Testing the Superiority of CHF 1535 pMDI 800/24µg Total Daily Dose Compared With CHF 718 pMDI 800µg Total Daily Dose in Adults With Asthma on Medium or High-Dose Inhaled Corticosteroidcompletedn=1,377
• phase3Study on Foster Efficacy Maintenance and Reliever vs Foster Maintenance + Salbutamol Reliever in Asthmatics (MART2)completedn=1,714
• phase3Functional Respiratory Imaging Study (DARWiIN)completedn=25
• phase3Study in Adult Patients With Moderate to Severe Asthmacompletedn=78
• phase3A Study Comparing Efficacy, Safety and Tolerability of the Fixed Dose Triple Combination CHF 5993 With the Fixed Dose Dual Combination CHF 1535 in Subjects With COPDcompletedn=3,433
• phase4Linear Growth Study (0476-097)(COMPLETED)completedn=360
• phase2To Investigate Drug-drug Interaction and Relative Bioavailability Between the FDC AzelastineHCL/Beclomethasone Dipropionate Nasal Spray, & Beclomethasone Dipropionate Nasal Spray in the Test Vehicle, and RinoClenil® Nasal Spraycompletedn=48